Ralliant Corporation (NYSE:RAL) Receives $57.89 Average Price Target from Analysts

Shares of Ralliant Corporation (NYSE:RAL) have received an average rating of “Moderate Buy” from the twelve brokerages that are presently covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $58.00.

A number of analysts recently issued reports on the company. Citigroup raised Ralliant from a “neutral” rating to a “buy” rating and lifted their target price for the company from $53.00 to $61.00 in a research report on Monday, December 8th. Truist Financial assumed coverage on Ralliant in a research note on Friday, December 12th. They issued a “buy” rating and a $62.00 price target for the company. Barclays upped their price objective on Ralliant from $59.00 to $60.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 7th. Oppenheimer increased their price objective on Ralliant from $55.00 to $60.00 and gave the company an “outperform” rating in a report on Monday, December 15th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Ralliant in a report on Monday, December 29th.

Hedge Funds Weigh In On Ralliant

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Farmers & Merchants Investments Inc. acquired a new position in Ralliant during the second quarter worth approximately $662,000. GAMMA Investing LLC bought a new position in shares of Ralliant during the 2nd quarter worth approximately $56,000. Alpha Omega Wealth Management LLC acquired a new position in shares of Ralliant during the 2nd quarter worth approximately $213,000. Public Employees Retirement System of Ohio acquired a new position in shares of Ralliant during the 2nd quarter worth approximately $1,799,000. Finally, TD Private Client Wealth LLC bought a new stake in Ralliant in the 2nd quarter valued at $284,000.

Ralliant Stock Up 0.7%

Shares of RAL stock opened at $52.89 on Tuesday. Ralliant has a 12 month low of $40.70 and a 12 month high of $55.08. The stock has a fifty day simple moving average of $49.50. The company has a market capitalization of $5.97 billion and a price-to-earnings ratio of 41.65. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.03 and a current ratio of 1.49.

Ralliant (NYSE:RAL) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.02. The business had revenue of $529.10 million during the quarter, compared to analyst estimates of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Monday, December 8th were paid a dividend of $0.05 per share. The ex-dividend date was Monday, December 8th. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. Ralliant’s payout ratio is currently 15.75%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.